Company intelligence
Artivion EMEA
Advancing Aortic Technologies With Purpose™
About Artivion EMEA
Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impact. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. Artivion has over 1,600 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, Hechingen, Germany, and Herzliya, Israel. Additionally, it has sales and distribution offices in various countries throughout Europe, Asia, and South America.
Verified activity
Signals from Artivion EMEA
2 published signals
Presence & Recognition
Artivion EMEA is attending the EACTS 2026 conference in Barcelona from 7 to 10 October 2026.
Reported by Artivion EMEA
Partnerships
Artivion EMEA is highlighting its partnership with surgeons worldwide to advance the treatment of aortic disease during September as Aortic Disease Awareness Month
Reported by Artivion EMEA